Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What makes gouty inflammation so variable?
Robert Terkeltaub
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Georgiana Cabău, Tania O. Crişan, Viola Klück, et al.
Immunological Reviews (2019) Vol. 294, Iss. 1, pp. 92-105
Open Access | Times Cited: 195
Gout and Diet: A Comprehensive Review of Mechanisms and Management
Yingling Zhang, Simin Chen, Man Yuan, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3525-3525
Open Access | Times Cited: 71
Mouse models for human hyperuricaemia: a critical review
Jie Lü, Nicola Dalbeth, Huiyong Yin, et al.
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 7, pp. 413-426
Closed Access | Times Cited: 138
The biology of urate
Robert T. Keenan
Seminars in Arthritis and Rheumatism (2020) Vol. 50, Iss. 3, pp. S2-S10
Open Access | Times Cited: 114
Autoinflammatory Features in Gouty Arthritis
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1880-1880
Open Access | Times Cited: 76
The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation
Ori Scott, Ekambir Saran, Spencer A. Freeman
EMBO Reports (2025)
Open Access | Times Cited: 1
Investigational drugs for hyperuricemia, an update on recent developments
Tristan Pascart, Pascal Richette
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 5, pp. 437-444
Closed Access | Times Cited: 72
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation
Federica Raucci, Asif Iqbal, Anella Saviano, et al.
Pharmacological Research (2019) Vol. 147, pp. 104351-104351
Open Access | Times Cited: 59
Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank
Ruth Topless, Amanda Phipps‐Green, Megan Leask, et al.
ACR Open Rheumatology (2021) Vol. 3, Iss. 5, pp. 333-340
Open Access | Times Cited: 49
Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment
Hanlin Xu, Bohan Zhang, Yaxin Chen, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 3, pp. 416-427
Closed Access | Times Cited: 33
Mechanisms of theaflavins against gout and strategies for improving the bioavailability
Jingzi Chen, Yanchao Zheng, Sihan Gong, et al.
Phytomedicine (2023) Vol. 114, pp. 154782-154782
Closed Access | Times Cited: 19
uPA/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action
Palani Dinesh, Mahaboobkhan Rasool
Pharmacological Research (2018) Vol. 134, pp. 31-39
Closed Access | Times Cited: 53
Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications
Nicole Leung, Kevin Yip, Michael H. Pillinger, et al.
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 7, pp. 1345-1362
Open Access | Times Cited: 27
Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia
Khaled A. Elsaid, Tony R. Merriman, Leigh‐Ana Rossitto, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 5, pp. 794-805
Open Access | Times Cited: 26
The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target
Paulo Vinícius Gil Alabarse, Patrícia Gnieslaw de Oliveira, Huaping Qin, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 739-751
Open Access | Times Cited: 6
Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout
Zengmiao Wang, Ying Zhao, Amanda Phipps‐Green, et al.
Arthritis & Rheumatology (2019) Vol. 72, Iss. 5, pp. 802-814
Open Access | Times Cited: 36
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review
Huai Leng Pisaniello, Mark Fisher, Hamish Farquhar, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Modified Baihu decoction therapeutically remodels gut microbiota to inhibit acute gouty arthritis
Xianyang Wang, Haishan Long, Ming Chen, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 22
The Anti-hyperuricemia and Anti-inflammatory Effects of Atractylodes Macrocephala in Hyperuricemia and Gouty Arthritis Rat Models
Yiyuan Luo, Xvwu Qian, Ying Jiang, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 5, pp. 950-964
Closed Access | Times Cited: 20
Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
Monosodium urate crystals alter the circadian clock in macrophages leading to loss of NLRP3 inflammasome repression: Implications for timing of the gout flare
Dmitry Popov, Lekha Jain, Mariam Alhilali, et al.
The FASEB Journal (2023) Vol. 37, Iss. 6
Open Access | Times Cited: 12
Uric acid en route to gout
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms
Mengyuan Li, Fei Tian, Jinling Guo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
Carlos Rodríguez‐Navarro, Kerstin Elert, Aurelia Ibáñez-Velasco, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling
Charles A. McWherter, Yun‐Jung Choi, Ramón Serrano, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top